Ordinary Medicine

Extraordinary Treatments, Longer Lives, and Where to Draw the Line

Sharon R. Kaufman (Autor)

Buch | Softcover

336 Seiten

2015
Duke University Press (Verlag)
978-0-8223-5888-6 (ISBN)

Artikel merken

Sharon R. Kaufman examines the quandary of patients, families and doctors not knowing the point where enough medical treatment becomes too much treatment. A hidden chain of drivers among science, industry, new technology, and insurance spur this quandary, serving to obscure the ability to identify the difference between extraordinary and ordinary medicine.

Most of us want and expect medicine’s miracles to extend our lives. In today’s aging society, however, the line between life-giving therapies and too much treatment is hard to see—it’s being obscured by a perfect storm created by the pharmaceutical and biomedical industries, along with insurance companies. In Ordinary Medicine Sharon R. Kaufman investigates what drives that storm’s “more is better” approach to medicine: a nearly invisible chain of social, economic, and bureaucratic forces that has made once-extraordinary treatments seem ordinary, necessary, and desirable. Since 2002 Kaufman has listened to hundreds of older patients, their physicians and family members express their hopes, fears, and reasoning as they faced the line between enough and too much intervention. Their stories anchor Ordinary Medicine. Today’s medicine, Kaufman contends, shapes nearly every American’s experience of growing older, and ultimately medicine is undermining its own ability to function as a social good. Kaufman’s careful mapping of the sources of our health care dilemmas should make it far easier to rethink and renew medicine’s goals.

Sharon R. Kaufman is Chair of the Department of Anthropology, History and Social Medicine at the University of California, San Francisco. She is the author of …And a Time to Die: How American Hospitals Shape the End of Life.

Acknowledgments ix

Introduction. Diagnosing Twenty-First-Century Health Care 1

Part I: The Quandry and Unexamined Ordinariness of Twenty-First-Century Medicine

1. Ordinary Medicine in Our Aging Society: The Dilemma of Longevity 21

Part II. The Chain of Health Care Drivers

2. The Medical-Industrial Complex I: Evidence-Based Medicine, the Biomedical Economy, and the Ascendance of Clinical Trials 53

3. The Medical-Industrial Complex II: Access, Industry, and the Clincial Trials Phenomenon 79

4. "Reimbursement Is Critical for Everything": Medicare and the Ethics of Managing Life 99

Part III: Medicine's Changing Means and Ends

5. Standard and Necessary Treatments: The Changing Means and Ends of Technology 127

6. Family Matters: Kidneys and New Forms of Care 165

7. Influencing the Character of the Future: Prognosis, Risk, and Time Left 195

8. For Whose Benefit? Our Shared Quandary 217

Conclusion. Toward a New Social Contract? 238

Notes on the Research 249

Notes 255

Bibliography 285

Index 307

Erscheint lt. Verlag	29.5.2015
Reihe/Serie	Critical Global Health: Evidence, Efficacy, Ethnography
Verlagsort	North Carolina
Sprache	englisch
Maße	152 x 229 mm
Gewicht	476 g
Themenwelt	Sachbuch/Ratgeber ► Gesundheit / Leben / Psychologie
	Medizin / Pharmazie ► Gesundheitswesen
	Studium ► 2. Studienabschnitt (Klinik) ► Humangenetik
	Studium ► Querschnittsbereiche ► Geschichte / Ethik der Medizin
ISBN-10	0-8223-5888-3 / 0822358883
ISBN-13	978-0-8223-5888-6 / 9780822358886
Zustand	Neuware